ÔçÒÒŮѸÀ×

    1. <form id=SSjMaZxIp><nobr id=SSjMaZxIp></nobr></form>
      <address id=SSjMaZxIp><nobr id=SSjMaZxIp><nobr id=SSjMaZxIp></nobr></nobr></address>

      Passive

      iShares Neuroscience and Healthcare ETF

      The iShares Neuroscience and Healthcare ETF (the ¡°Fund¡±) seeks to track the investment results of an index composed of U.S. and non-U.S. companies that could benefit from the growth and innovation in neuroscience.

      $25.90

      Compare similar ETFs

      Fund Size
      Dividend
      Fees
      Current
      Neuroscience and Healthcare ETF IBRN
      Fund Size
      $4.1M
      Dividend
      0.0%
      Fees
      -
      Total Stock Market Index Fund VTSAX
      Fund Size
      $1.7T
      Dividend
      -
      Fees
      -
      Total Stock Market Index Fund VTI
      Fund Size
      $1.7T
      Dividend
      1.2%
      Fees
      0.03%
      500 Index Fund VFIAX
      Fund Size
      $1.49T
      Dividend
      -
      Fees
      -
      500 Index Fund VOO
      Fund Size
      $1.49T
      Dividend
      1.2%
      Fees
      0.03%
      View 1315 similar ETFs →

      Average metrics of all companies in portfolio

      Compare to
      Market
      Market Cap The market value of the company. It's calculated by multiplying the share price by the number of outstanding shares. $5.95B
      Dividend Yield Yearly payout to shareholders per share. The percentage indicates the payout in relation to the share price. 0.0 %
      Beta Indicates the relationship between the price performance of a share and the market. 0.8979
      P/E Ratio Ratio between share price and earnings per share. A low ratio could indicate that the stock is undervalued or investors aren't expecting high growth. A high ratio could indicate that the stock is overvalued or investors are expecting high growth. 29.07
      Negative P/E Ratio a negative P/E ratio shows that the company is not profitable, and it shows how many years it would take the company to lose its entire market capitalisation if it did not change anything -33.71
      Profitable Companies 41
      PEG The ratio between the P/E ratio and the growth rate of the company's earnings per share in the last twelve months. A lower PEG could mean that a stock is undervalued. 101.06
      Price to Sales Ratio Market cap divided by the revenue in the most recent year. 4.38
      Price to Book Ratio Price to Book Ratio is the Market cap divided by the Book value of the company 3.77
      Compare to
      Market
      Enterprise Value to EBIT Enterprise Value divided by EBIT 24.85
      Enterprise Value to Revenue Enterprise value divided by revenue 45.51
      Total Debt to Enterprise Value Total debt divided by enterprise value 0.09
      Debt to Equity A higher ratio indicates a higher risk. However, the ratio is difficult to compare between industries where common amounts of debt vary. NaN
      Profit Margin Net income divided by revenue of the last 4 quarters. It indicates the company's profitability. 444.77%
      Quarterly Earnings Growth (YoY) The rate at which the company's net income has increased to the same quarter one year ago. -
      Return on Equity Equity divided by market cap. -252.36%
      Return on Assets Indicates a company's profitability in relation to its total assets. -163.96%
      Return on Invested Capital Return on invested capital (ROIC) is net income after dividends divided by the sum of debt and equity. It shows how effective a company is at turning capital invested by shareholders and other debtholders into profits. -213.53%

      Industries

      Healthcare 67.8%
      Other 8.5%
      N/A 23.7%

      Market cap

      Micro Cap 9%
      Small Cap 32%
      Mid Cap 42%
      Large Cap 17%
      Mega Cap 0%

      59 Investments

      P/E-Ratio
      Total Investment
      Weight
      BlackRock Funds III logo

      BlackRock Funds III

      P/E-Ratio
      n/a
      Total Investment
      $350k
      Weight
      10.3%
      Catalyst Pharmaceuticals Inc logo

      CPRX - Manufacturing

      Catalyst Pharmaceuticals Inc

      P/E-Ratio
      12.1
      Total Investment
      $170k
      Weight
      5.0%
      Argenx SE logo

      ARGX - Manufacturing

      Argenx SE

      P/E-Ratio
      46.3
      Total Investment
      $167k
      Weight
      4.9%
      Xenon Pharmaceuticals Inc logo

      XENE - Manufacturing

      Xenon Pharmaceuticals Inc

      P/E-Ratio
      -11.0
      Total Investment
      $161k
      Weight
      4.7%
      SK Biopharmaceuticals Co Ltd logo

      SK Biopharmaceuticals Co Ltd

      P/E-Ratio
      n/a
      Total Investment
      $156k
      Weight
      4.6%
      Denali Therapeutics Inc logo

      DNLI - Manufacturing

      Denali Therapeutics Inc

      P/E-Ratio
      -5.5
      Total Investment
      $153k
      Weight
      4.5%
      Neurocrine Biosciences Inc logo

      NBIX - Manufacturing

      Neurocrine Biosciences Inc

      P/E-Ratio
      39.7
      Total Investment
      $146k
      Weight
      4.3%
      PTC Therapeutics Inc logo

      PTCT - Manufacturing

      PTC Therapeutics Inc

      P/E-Ratio
      6.1
      Total Investment
      $146k
      Weight
      4.3%
      Scholar Rock Holding Corp logo

      SRRK - Professional, Scientific, and Technical Services

      Scholar Rock Holding Corp

      P/E-Ratio
      -11.7
      Total Investment
      $141k
      Weight
      4.1%
      Supernus Pharmaceuticals Inc logo

      SUPN - Manufacturing

      Supernus Pharmaceuticals Inc

      P/E-Ratio
      39.2
      Total Investment
      $135k
      Weight
      4.0%
      Alkermes PLC logo

      Alkermes PLC

      P/E-Ratio
      n/a
      Total Investment
      $129k
      Weight
      3.8%
      ACADIA Pharmaceuticals Inc logo

      ACAD - Manufacturing

      ACADIA Pharmaceuticals Inc

      P/E-Ratio
      19.6
      Total Investment
      $128k
      Weight
      3.8%
      Biogen Inc logo

      BIIB - Manufacturing

      Biogen Inc

      P/E-Ratio
      12.6
      Total Investment
      $124k
      Weight
      3.6%
      Biohaven Ltd logo

      BHVN - Manufacturing

      Biohaven Ltd

      P/E-Ratio
      -2.1
      Total Investment
      $114k
      Weight
      3.3%
      H Lundbeck A/S logo

      H Lundbeck A/S

      P/E-Ratio
      n/a
      Total Investment
      $100k
      Weight
      2.9%
      Sarepta Therapeutics Inc logo

      SRPT - Manufacturing

      Sarepta Therapeutics Inc

      P/E-Ratio
      -30.8
      Total Investment
      $93.1k
      Weight
      2.7%
      Edgewise Therapeutics Inc logo

      EWTX - Manufacturing

      Edgewise Therapeutics Inc

      P/E-Ratio
      -10.0
      Total Investment
      $86.1k
      Weight
      2.5%
      Integra LifeSciences Holdings Corp logo

      IART - Manufacturing

      Integra LifeSciences Holdings Corp

      P/E-Ratio
      -2.3
      Total Investment
      $84.7k
      Weight
      2.5%
      Dyne Therapeutics Inc logo

      DYN - Manufacturing

      Dyne Therapeutics Inc

      P/E-Ratio
      -11.7
      Total Investment
      $77.4k
      Weight
      2.3%
      Dynavox Group AB logo

      Dynavox Group AB

      P/E-Ratio
      n/a
      Total Investment
      $67.7k
      Weight
      2.0%
      Neuren Pharmaceuticals Ltd logo

      Neuren Pharmaceuticals Ltd

      P/E-Ratio
      n/a
      Total Investment
      $65.4k
      Weight
      1.9%
      BioArctic AB logo

      BioArctic AB

      P/E-Ratio
      n/a
      Total Investment
      $62.2k
      Weight
      1.8%
      Avadel Pharmaceuticals PLC logo

      AVDL - Manufacturing

      Avadel Pharmaceuticals PLC

      P/E-Ratio
      -488.4
      Total Investment
      $61.3k
      Weight
      1.8%
      Anavex Life Sciences Corp logo

      AVXL - Manufacturing

      Anavex Life Sciences Corp

      P/E-Ratio
      -23.6
      Total Investment
      $61.2k
      Weight
      1.8%
      SanBio Co Ltd logo

      SanBio Co Ltd

      P/E-Ratio
      n/a
      Total Investment
      $57.7k
      Weight
      1.7%
      HoMEÔçÒÒŮѸÀ×